Literature DB >> 8370919

Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.

V Fatourechi1, J A Garrity, G B Bartley, E J Bergstralh, C A Gorman.   

Abstract

Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves' disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves' ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989-1990 questionnaire (83% response rate, n = 364), 89.1% without (n = 319) and 88.9% with (n = 45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.

Entities:  

Mesh:

Year:  1993        PMID: 8370919     DOI: 10.1007/BF03348875

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

Authors:  J P KRISS; V PLESHAKOV; J R CHIEN
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  Localized myxedema involving the upper extremities.

Authors:  B D COHEN; R S BENUA; R W RAWSON
Journal:  Arch Intern Med       Date:  1963-05

3.  Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment.

Authors:  H R Atta; G McCreath; J H McKillop; J V Forrester; J A Thomson; R Wilson; H W Gray
Journal:  Scott Med J       Date:  1990-04       Impact factor: 0.729

4.  Pretibial myxedema and nonthyrotoxic thyroid disease.

Authors:  P J Lynch; J C Maize; J C Sisson
Journal:  Arch Dermatol       Date:  1973-01

5.  Selection of patients and choice of operation for orbital decompression in graves ophthalmopathy.

Authors:  L W DeSanto; C A Gorman
Journal:  Laryngoscope       Date:  1973-06       Impact factor: 3.325

6.  Ophthalmopathy of Graves' disease treated by removal of roof, lateral walls, and lateral sphenoid ridge: review of 46 cases.

Authors:  C S MacCarty; T P Kenefick; W M McConahey; T P Kearns
Journal:  Mayo Clin Proc       Date:  1970-07       Impact factor: 7.616

7.  Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Authors:  L M Lipman; D E Green; N J Snyder; J C Nelson; D H Solomon
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

8.  Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.

Authors:  S C Werner; C R Feind; M Aida
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

9.  Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.

Authors:  J C Morris; I D Hay; R E Nelson; N S Jiang
Journal:  Mayo Clin Proc       Date:  1988-07       Impact factor: 7.616

10.  Unusual locations of localized myxedema in Graves' disease. Report of three cases.

Authors:  N Noppakun; K Bancheun; S Chandraprasert
Journal:  Arch Dermatol       Date:  1986-01
View more
  2 in total

Review 1.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

2.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.